Pluri Inc.
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- biotechnology [1]
- Company / filing name
- Pluri Inc. [2]
- Headquarters location
- Haifa [1]
- Founded
- 2001 [1]
- Legal form
- limited company [1]
- Official website
- https://pluri-biotech.com/; https://www.pluristem.com/hebrew [1]
- CIK
- 1158780 [2]
- Country in background record
- United States; Israel [1]
- Symbols / exchanges
- PLUR (Nasdaq) [2]
Company positioning and business
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. [3]
Background text: Wikipedia contributors, Pluri Inc.. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
Listed securities: PLUR (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was Pluri Inc. founded?
Founded: 2001. The linked source provides the background record. [1]
Where is the headquarters of Pluri Inc.?
Headquarters location: Haifa. The linked source provides the background record. [1]
Which business sectors are recorded for Pluri Inc.?
Business sectors: biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Pluri Inc. (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.